Low Libido in Women: Causes, Treatments, and Why Your Doctor Should Ask

Here's a question your doctor has probably never asked you: "How's your sex drive?"

It's one of the most important quality-of-life questions in women's health, and it's almost universally skipped. Partly because doctors are uncomfortable asking. Partly because they don't have great training on what to do with the answer. And partly because there's a pervasive cultural assumption that women's sexual desire is too complicated to address medically — so why bother asking.

Low libido in women is common, it's distressing, and in many cases, it's treatable. But you have to bring it up, because no one else is going to.

How Common Is This?

Studies consistently show that roughly 10% of women meet criteria for Hypoactive Sexual Desire Disorder (HSDD) — clinically low sexual desire that causes personal distress. When you broaden the definition to include women who report decreased desire without meeting strict diagnostic criteria, the number rises to 25-40%.

HSDD prevalence increases with age but is not exclusive to older women. It occurs premenopausally, postpartum, in perimenopause, and post-menopause. It's not just a menopause problem.

The Causes Are Usually Multi-Layered

Low libido in women almost never has a single cause. It's typically a combination of factors that interact and compound each other.

Hormonal Factors

Testosterone decline. Women produce testosterone from the ovaries and adrenal glands, and levels decline gradually starting in the late 20s. By menopause, testosterone levels are roughly half of what they were at age 20. Testosterone is the primary driver of sexual desire in both men and women. When it drops below a critical threshold, desire drops with it.

Estrogen decline. Particularly relevant in menopause. Estrogen maintains vaginal lubrication, elasticity, and blood flow. When estrogen drops, vaginal dryness and atrophy make sex uncomfortable or painful — and pain is a powerful libido killer. It's hard to desire something that hurts.

Progesterone. High progesterone levels (late luteal phase, pregnancy, certain birth control formulations) can suppress libido.

Thyroid dysfunction. Both hypothyroidism and hyperthyroidism affect sexual desire. Fatigue, weight changes, and mood disturbances from thyroid disease compound the effect.

Elevated prolactin. Less common but worth checking if libido loss is accompanied by menstrual irregularity or galactorrhea (nipple discharge).

Medication-Related

SSRIs and SNRIs. These are the most notorious libido killers. Selective serotonin reuptake inhibitors (sertraline, fluoxetine, paroxetine, etc.) cause sexual dysfunction — including decreased desire, difficulty with arousal, and anorgasmia — in roughly 40-70% of users. This is underreported because patients don't mention it and doctors don't ask.

Hormonal contraceptives. Oral contraceptives increase SHBG, which binds free testosterone and reduces its availability. Some women experience significant libido suppression on the pill. Switching formulations or methods sometimes helps.

Blood pressure medications. Beta-blockers and certain diuretics can impair sexual function.

Antihistamines. Chronic use can affect vaginal lubrication and arousal.

Psychological and Relational

Stress and mental load. The cognitive burden of managing a household, children, career, and relationships leaves little mental bandwidth for desire. Sexual desire requires a degree of psychological space that chronic overwhelm eliminates.

Depression and anxiety. Both conditions independently suppress libido — and then the medications used to treat them suppress it further. Double suppression.

Relationship quality. Resentment, unresolved conflict, feeling unappreciated, or emotional disconnection from a partner directly impact desire. No medication fixes this.

Body image. Feeling uncomfortable in your body — whether from weight changes, postpartum changes, or aging — can profoundly affect sexual confidence and desire.

History of trauma. Sexual trauma or abuse can create complex associations between sex and safety that affect desire in ways that require specialized therapeutic support.

Physical

Chronic pain. Endometriosis, vulvodynia, interstitial cystitis, fibromyalgia, and other chronic pain conditions make sex painful or exhausting.

Genitourinary syndrome of menopause (GSM). Vaginal dryness, atrophy, and urinary symptoms caused by estrogen decline. Affects up to 50% of postmenopausal women and directly makes sex uncomfortable.

Pelvic floor dysfunction. Hypertonic pelvic floor muscles cause dyspareunia (painful intercourse), which suppresses desire over time.

Fatigue. From any cause — iron deficiency, sleep deprivation, thyroid disease, chronic illness. Exhaustion trumps desire every time.

The Workup

A proper evaluation for low libido should include:

Lab work:

• Total and free testosterone
• SHBG
• DHEA-S
• Estradiol
• TSH, free T4
• Prolactin (if indicated)
• Ferritin, CBC
• Comprehensive metabolic panel

Medication review. Every medication and supplement, with specific attention to SSRIs, hormonal contraceptives, beta-blockers, and antihistamines.

Sexual history. Onset (lifelong vs. acquired), situational vs. generalized, pain with intercourse, ability to orgasm, and current relationship status and satisfaction.

Mental health screening. Depression, anxiety, and trauma history.

Pelvic exam. Assessing for vulvovaginal atrophy, pelvic floor tenderness, and other physical causes of pain.

Treatments That Work

Hormonal

Testosterone therapy. Off-label testosterone (typically compounded topical cream at 0.5-1 mg daily) is the most consistently effective pharmacological treatment for HSDD in postmenopausal women. Multiple randomized controlled trials show significant improvements in sexual desire, arousal, orgasm, and satisfaction.

Testosterone therapy in premenopausal women has less robust data but is used clinically with monitoring. The goal is to restore testosterone to the normal premenopausal range, not to supraphysiologic levels.

Side effects at appropriate doses are generally mild — occasional acne, slightly increased facial hair. These are dose-dependent and reversible.

Local estrogen. For women with GSM causing painful sex, vaginal estrogen (cream, tablet, or ring) restores vaginal tissue health, improves lubrication, and eliminates dyspareunia. This addresses one of the most common physical barriers to desire.

Systemic HRT. Estrogen replacement during menopause improves sleep, mood, energy, and vaginal health — all of which indirectly support libido.

Non-Hormonal Medications

Flibanserin (Addyi). FDA-approved for premenopausal HSDD. It modulates serotonin and dopamine in brain circuits related to sexual desire. The effect is modest — roughly one additional "satisfying sexual event" per month compared to placebo. It requires daily dosing, cannot be combined with alcohol, and causes dizziness and low blood pressure. It's an option, but not a strong one.

Bremelanotide (Vyleesi). FDA-approved for premenopausal HSDD. An injectable (subcutaneous) medication taken as-needed before anticipated sexual activity. It acts on melanocortin receptors in the brain. Side effects include nausea (in about 40% of users), headache, and flushing. Modest efficacy, but some women find it helpful.

SSRI-Related Solutions

If an SSRI is the culprit:

• Switch to bupropion. Bupropion (Wellbutrin) has a different mechanism and does not cause sexual dysfunction — in fact, it can improve desire. It can be used as an antidepressant alternative or added to an SSRI to counteract sexual side effects.
• Dose reduction. If clinically appropriate, reducing the SSRI dose may restore sexual function while maintaining mood benefits.
• Switch to a lower-risk SSRI. Within the class, sertraline and paroxetine have the highest rates of sexual dysfunction. Escitalopram or vilazodone may have somewhat lower rates.

Psychological

Sex therapy / couples counseling. For relationship-mediated low desire, therapy is often more effective than any medication. A skilled therapist can address communication, expectations, and patterns that suppress desire.

Cognitive behavioral therapy. For anxiety, body image issues, or trauma-related sexual avoidance.

Mindfulness-based interventions. Growing evidence supports mindfulness techniques for improving sexual desire and arousal, particularly in women who are "in their heads" during sexual situations.

Why This Matters

Low libido isn't a luxury problem. Sexual health is a component of overall health recognized by the World Health Organization. Persistent low desire that causes distress affects quality of life, self-esteem, and relationship satisfaction. Dismissing it with "that's normal for your age" or "have you tried a glass of wine?" is inadequate care.

Women deserve the same thorough, evidence-based approach to sexual dysfunction that has been standard for men since Viagra launched in 1998. We're behind, but the tools exist.

If your sex drive has disappeared and nobody's asking why, [book with CORAL](https://coral.clinic). We ask the questions other providers skip.